Axonics Reports First Quarter 2024 Financial Results
Axonics, Inc. (AXNX)
Last axonics, inc. earnings: 3/4 04:01 pm
Check Earnings Report
Company Research
Source: Business Wire
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a medical technology company that develops and commercializes innovative and minimally invasive products to treat bladder and bowel dysfunction, today reported financial results for the three months ended March 31, 2024.“Our commercial team continued to execute at a high level in the first quarter, generating revenue growth of 29% year over year across our portfolio of incontinence products,” said Raymond W. Cohen, chief executive officer. “Our growth was driven by higher utilization and share of wallet for existing sacral neuromodulation customers and the onboarding of new accounts. In addition, gross margin expanded to 75.8%, a new record, as we benefited from higher yields that were achieved through the diligent efforts of our manufacturing and operations team in Irvine.”Mr. Cohen continued, “We remain confident that our commitment to innovation, quality, direct-to-consumer advertising and providing strong clinical
Show less
Read more
Impact Snapshot
Event Time:
AXNX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXNX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXNX alerts
High impacting Axonics, Inc. news events
Weekly update
A roundup of the hottest topics
AXNX
News
- Axonics secures Australia's TGA approval for F15 SNM system [Yahoo! Finance]Yahoo! Finance
- Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia [Yahoo! Finance]Yahoo! Finance
- Axonics Receives Regulatory Approval for Recharge-Free SNM System in AustraliaBusiness Wire
- Axonics, Inc. (NASDAQ: AXNX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.MarketBeat
- Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash [Seeking Alpha]Seeking Alpha
AXNX
Earnings
- 10/30/23 - Beat
AXNX
Sec Filings
- 4/30/24 - Form 10-Q
- 4/30/24 - Form 8-K
- 4/29/24 - Form 10-K/A
- AXNX's page on the SEC website